Clinical trial
CASPAR: Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral…
NCT00174759 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174759 |
|---|---|
| Title | CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease |
| Official title | A Double-blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d,in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft. |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Drug |
| Interventions | Clopidogrel |
| Enrollment | 1,460 |
| Start date | Sep 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 11, 2011 |
| Countries | Australia, Austria, Belgium, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: